259 related articles for article (PubMed ID: 36246881)
1. CmPn signaling networks in the tumorigenesis of breast cancer.
Renteria M; Belkin O; Jang D; Aickareth J; Bhalli M; Zhang J
Front Endocrinol (Lausanne); 2022; 13():1013892. PubMed ID: 36246881
[No Abstract] [Full Text] [Related]
2. Zinc's Association with the CmPn/CmP Signaling Network in Breast Cancer Tumorigenesis.
Renteria M; Belkin O; Aickareth J; Jang D; Hawwar M; Zhang J
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36421686
[TBL] [Abstract][Full Text] [Related]
3. CCM signaling complex (CSC) couples both classic and non-classic Progesterone receptor signaling.
Abou-Fadel J; Jiang X; Grajeda B; Padarti A; Ellis CC; Flores E; Cailing-De La O AD; Zhang J
Cell Commun Signal; 2022 Aug; 20(1):120. PubMed ID: 35971177
[TBL] [Abstract][Full Text] [Related]
4. Key Members of the CmPn as Biomarkers Distinguish Histological and Immune Subtypes of Hepatic Cancers.
Abou-Fadel J; Reid V; Le A; Croft J; Zhang J
Diagnostics (Basel); 2023 Mar; 13(6):. PubMed ID: 36980321
[TBL] [Abstract][Full Text] [Related]
5. CmP Signaling Network Leads to Identification of Prognostic Biomarkers for Triple-Negative Breast Cancer in Caucasian Women.
Abou-Fadel J; Bhalli M; Grajeda B; Zhang J
Genet Test Mol Biomarkers; 2022 Apr; 26(4):198-219. PubMed ID: 35481969
[No Abstract] [Full Text] [Related]
6. Biomarkers derived from CmP signal network in triple negative breast cancers.
Sanchez N; Harvey C; Vincent D; Croft J; Zhang J
Transl Breast Cancer Res; 2023; 4():21. PubMed ID: 38751477
[TBL] [Abstract][Full Text] [Related]
7. Membrane Progesterone Receptors (mPRs/PAQRs) Are Going beyond Its Initial Definitions.
Aickareth J; Hawwar M; Sanchez N; Gnanasekaran R; Zhang J
Membranes (Basel); 2023 Feb; 13(3):. PubMed ID: 36984647
[TBL] [Abstract][Full Text] [Related]
8. mPR-Specific Actions Influence Maintenance of the Blood-Brain Barrier (BBB).
Abou-Fadel J; Jiang X; Padarti A; Goswami DG; Smith M; Grajeda B; Bhalli M; Le A; Walker WE; Zhang J
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077089
[TBL] [Abstract][Full Text] [Related]
9. Acquired convergence of hormone signaling in breast cancer: ER and PR transition from functionally distinct in normal breast to predictors of metastatic disease.
Hilton HN; Doan TB; Graham JD; Oakes SR; Silvestri A; Santucci N; Kantimm S; Huschtscha LI; Ormandy CJ; Funder JW; Simpson ER; Kuczek ES; Leedman PJ; Tilley WD; Fuller PJ; Muscat GE; Clarke CL
Oncotarget; 2014 Sep; 5(18):8651-64. PubMed ID: 25261374
[TBL] [Abstract][Full Text] [Related]
10. BRCA1-associated mammary tumorigenesis is dependent on estrogen rather than progesterone signaling.
van de Ven M; Liu X; van der Burg E; Klarenbeek S; Alexi X; Zwart W; Dijcks F; Bouwman P; Jonkers J
J Pathol; 2018 Sep; 246(1):41-53. PubMed ID: 29877575
[TBL] [Abstract][Full Text] [Related]
11. Expression and transcriptional activity of progesterone receptor A and progesterone receptor B in mammalian cells.
Graham JD; Clarke CL
Breast Cancer Res; 2002; 4(5):187-90. PubMed ID: 12223122
[TBL] [Abstract][Full Text] [Related]
12. miRNAs in breast cancer tumorigenesis (Review).
Zhang ZJ; Ma SL
Oncol Rep; 2012 Apr; 27(4):903-10. PubMed ID: 22200848
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor signaling is reprogrammed during breast tumorigenesis.
Chi D; Singhal H; Li L; Xiao T; Liu W; Pun M; Jeselsohn R; He H; Lim E; Vadhi R; Rao P; Long H; Garber J; Brown M
Proc Natl Acad Sci U S A; 2019 Jun; 116(23):11437-11443. PubMed ID: 31110002
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of ATBF1 by progesterone-PR signaling and its functional implication in mammary epithelial cells.
Li M; Zhao D; Ma G; Zhang B; Fu X; Zhu Z; Fu L; Sun X; Dong JT
Biochem Biophys Res Commun; 2013 Jan; 430(1):358-63. PubMed ID: 23159610
[TBL] [Abstract][Full Text] [Related]
15. Obesity associated alterations in the biology of adipose stem cells mediate enhanced tumorigenesis by estrogen dependent pathways.
Strong AL; Strong TA; Rhodes LV; Semon JA; Zhang X; Shi Z; Zhang S; Gimble JM; Burow ME; Bunnell BA
Breast Cancer Res; 2013; 15(5):R102. PubMed ID: 24176089
[TBL] [Abstract][Full Text] [Related]
16. Dermcidin exerts its oncogenic effects in breast cancer via modulation of ERBB signaling.
Bancovik J; Moreira DF; Carrasco D; Yao J; Porter D; Moura R; Camargo A; Fontes-Oliveira CC; Malpartida MG; Carambula S; Vannier E; Strauss BE; Wakamatsu A; Alves VA; Logullo AF; Soares FA; Polyak K; Belizário JE
BMC Cancer; 2015 Feb; 15():70. PubMed ID: 25879571
[TBL] [Abstract][Full Text] [Related]
17. Expression of membrane progesterone receptors (mPR/PAQR) in ovarian cancer cells: implications for progesterone-induced signaling events.
Charles NJ; Thomas P; Lange CA
Horm Cancer; 2010 Aug; 1(4):167-76. PubMed ID: 21761364
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of the BRCA1/long non-coding RNA NEAT1 signaling axis contributes to breast tumorigenesis.
Lo PK; Zhang Y; Wolfson B; Gernapudi R; Yao Y; Duru N; Zhou Q
Oncotarget; 2016 Oct; 7(40):65067-65089. PubMed ID: 27556296
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast Growth Factor Receptor 2 Signaling in Breast Cancer.
Lei H; Deng CX
Int J Biol Sci; 2017; 13(9):1163-1171. PubMed ID: 29104507
[TBL] [Abstract][Full Text] [Related]
20. Caveolin involvement and modulation in breast cancer.
Aoki MN; Amarante MK; Oda JM; Watanabe MA
Mini Rev Med Chem; 2011 Nov; 11(13):1143-52. PubMed ID: 22353223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
